BAGLIONI, SILVANA
 Distribuzione geografica
Continente #
NA - Nord America 1.204
EU - Europa 1.043
AS - Asia 163
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.416
Nazione #
US - Stati Uniti d'America 1.202
PL - Polonia 402
RU - Federazione Russa 250
SE - Svezia 83
IE - Irlanda 77
UA - Ucraina 55
IT - Italia 54
DE - Germania 48
HK - Hong Kong 45
SG - Singapore 43
CH - Svizzera 29
CN - Cina 26
JO - Giordania 22
FI - Finlandia 19
IN - India 19
GB - Regno Unito 16
BE - Belgio 5
SC - Seychelles 4
VN - Vietnam 4
FR - Francia 3
TR - Turchia 3
CA - Canada 2
EU - Europa 1
KR - Corea 1
MU - Mauritius 1
NL - Olanda 1
RO - Romania 1
Totale 2.416
Città #
Warsaw 402
Santa Clara 187
Fairfield 149
Jacksonville 99
Chandler 95
Dublin 77
Ashburn 75
Seattle 69
Woodbridge 66
Cambridge 55
Houston 54
Wilmington 50
Ann Arbor 37
Singapore 36
Hong Kong 35
Bern 29
Lawrence 19
Altamura 18
Boardman 18
Buffalo 18
Princeton 18
Mumbai 15
Boston 14
Beijing 13
New York 12
San Diego 8
Medford 6
Bari 5
Brussels 5
Florence 5
Hillsboro 5
Los Angeles 5
Yubileyny 5
Dong Ket 4
Munich 4
Auburn Hills 3
Frankfurt Am Main 3
Izmir 3
Milan 3
Moscow 3
Norwalk 3
Pune 3
Shanghai 3
Bremen 2
Phoenix 2
Rome 2
Toronto 2
Verona 2
West Jordan 2
Amsterdam 1
Andover 1
Cedar Knolls 1
Grafing 1
Helsinki 1
Islington 1
Nuremberg 1
Old Bridge 1
Portland 1
Seoul 1
Timisoara 1
Xingtai 1
Totale 1.760
Nome #
Characterization of human adult stem cell populations isolated from visceral and subcutaneous adipose tissue. 287
Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell 261
PPARgamma in Neuroblastoma. 204
Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion. 155
Susceptibility to refractory ulcerative colitis is associated with polymorphism in the hMLH1 mismatch repair gene. 136
A novel microdeletion syndrome with loss of the MSH2 locus and hereditary non-polyposis colorectal cancer. 132
Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas. 123
Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. 122
Thyroid hormones promote cell differentiation and up-regulate the expression of the seladin-1 gene in in vitro models of human neuronal precursors. 120
Simple and complex genetics of colorectal cancer susceptibility 113
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 110
A kindred with MYH-associated polyposis and pilomatricomas. 108
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas. 105
Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 104
Expression of the anti-apoptotic gene seladin-1 and octreotide-induced apoptosis in GH-secreting and in non-functioning pituitary adenomas. 96
Expression of cyclic adenosine 3'-5'-monophosphate (cAMP)-Responsive Element Binding Protein and Inducible-cAMP Early Repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene 88
Identification of a novel mutation in the AVP-NPII gene affecting the sixth intrachain disulfide bond of the neurophysin II moiety. 83
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells 83
Totale 2.430
Categoria #
all - tutte 5.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.719


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020327 0 0 0 0 49 58 43 61 42 24 46 4
2020/2021289 33 16 33 29 6 45 10 32 14 43 6 22
2021/2022130 5 18 10 4 3 2 10 3 5 7 40 23
2022/2023411 30 74 26 26 26 67 48 13 57 1 13 30
2023/2024134 3 14 17 9 15 26 2 39 0 3 1 5
2024/2025552 27 99 59 133 234 0 0 0 0 0 0 0
Totale 2.430